Table 1 Baseline characteristics of the two groups

Male (%)

117 (57.1)

89 (53.9)

0.546

Age (years old)

65.40 ± 9.48

71.58 ± 6.24

<0.001***

BMI (kg/m2)

24.34 ± 3.12

24.48 ± 3.64

0.690

Smoke (%)

41 (20.0)

34 (20.6)

0.885

Drink (%)

27 (13.2)

29 (17.6)

0.240

Heart failure (%)

5 (2.4)

14 (8.5)

0.009**

Hypertension (%)

105 (51.2)

120 (72.7)

<0.001***

Diabetes (%))

22 (10.7)

38 (23.0)

0.001**

Stroke/TIA (%)

13 (6.3)

49 (29.7)

<0.001***

Vascular disease (%)

16 (7.8)

24 (14.5)

0.038**

COPD (%)

3 (1.5)

3 (1.8)

0.789

Gout (%)

4 (2.0)

1 (0.6)

0.386

CCB (%)

40 (19.5)

32 (19.4)

0.977

Statins (%)

11 (5.4)

12 (7.3)

0.450

Diuretic (%)

8 (3.9)

2 (1.2)

0.195

ACEI/ARB (%)

49 (23.9)

26 (15.8)

0.053

Digoxin (%)

4 (2.0)

4 (2.4)

0.756

Antiplatelet drugs (%)

23 (11.2)

30 (18.2)

0.057

β-blocker (%)

34 (16.6)

16 (9.7)

0.054

RBC (×  10¹²/L)

4.54 ± 0.55

4.59 ± 0.52

0.397

HGB (g/L)

139.76 ± 15.79

139.27 ± 15.83

0.768

HCT (%)

41.72 ± 4.55

41.57 ± 4.29

0.746

MCHC (g/L)

3.35 ± 0.128

3.34 ± 0.135

0.889

MCV (fl)

91.95 ± 6.18

90.73 ± 5.05

0.043*

RDW-CV (%)

13.42 ± 2.37

13.67 ± 2.25

0.303

WBC (×10⁹/L)

6.45 ± 2.01

7.22 ± 2.50

0.001**

PLT (×10⁹/L)

176.01 ± 51.73

171.38 ± 53.15

0. 399

MPV (fl)

11.42 ± 1.08

12.08 ± 1.05

<0.001***

PDW (%)

14.84 ± 3.51

15.91 ± 2.94

0.002**

FIB (g/L)

2.97 ± 0.91

2.79 ± 0.70

0.056

D2 (mg/L)

0.36 (0.24–0.81)

0.71 (0.39–1.35)

<0.001***

UA (μmol/L)

360.91 ± 110.73

349.50 ± 103.19

0. 313

Cr (μmol/L)

82.37 ± 21.37

73.29 ± 23.09

<0.001***

LAD (mm)

37.83 ± 6.27

40.2 ± 5.90

0.001**

LVEF (%)

57.80 ± 7.45

57.04 ± 7.20

0.350

NLR

2.33 (1.71–3.58)

3.11 (1.94–5.44)

<0.001***

CHADS2

0.94 ± 0.93

2.07 ± 1.31

<0.001***

CHA2DS2-VASc

2.04 ± 1.31

3.54 ± 1.56

<0.001***